Bryan Sendrowski is a Partner on the External Operations team and Head of Corporate Finance at Deerfield, and joined the Firm in 2012. On the External Operations team, Mr. Sendrowski is responsible for the day to day oversight and management of certain investments in Deerfield’s Private Design and Healthcare Innovation Funds. He assumed the Head of Corporate Finance role in early 2021, and in this position, he oversees the financial management and related operating activities of several Deerfield legal entities, including Deerfield Management Company. Prior to joining Deerfield, Mr. Sendrowski was Chief Financial Officer of New American Therapeutics, a specialty pharmaceutical company that was funded and facilitated by Deerfield’s Private Design Funds. Before New American Therapeutics, he was Chief Financial Officer at Akrimax Pharmaceuticals, as well as Vice President and Controller of Reliant Pharmaceuticals. Mr. Sendrowski also previously served as a Senior Manager in the financial statement audit practice of KPMG with responsibility for the management of public and private company audits. He received his B.A. from Pace University and is licensed (inactive) as a Certified Public Accountant in the state of New Jersey.